Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 2/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | NQO1 | P15559 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 5/20 | 0.43 |
| ▸ | LMNA | P02545 | 3/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.43 |
| ▸ | RELA | Q04206 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 4/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6678264 | 0.85 | CYP3A4 (0.52) | LTA4HTP53CYP3A4NQO1MAPK1 | |
| SCHEMBL10881069 | 0.83 | TP53 (0.57) | LTA4HTP53CYP3A4NQO1MAPK1 | |
| SCHEMBL6680067 | 0.79 | LTA4H (0.61) | LTA4HTP53CYP3A4NQO1L3MBTL1 | |
| SCHEMBL19553639 | 0.78 | LTA4H (0.51) | LTA4HTP53NQO1MAPK1LMNA | |
| SCHEMBL21111863 | 0.76 | DRD1 (0.69) | LTA4HTP53CYP3A4MAPK1LMNA | |
| SCHEMBL431054 | 0.75 | NQO1 (0.70) | LTA4HNQO1RELAMAPTTDP1 | |
| SCHEMBL20873235 | 0.74 | ACHE (0.47) | CYP3A4RELASMN1; SMN2ALDH1A1CYP1A2 | |
| SCHEMBL2155506 | 0.73 | TP53 (0.53) | LTA4HTP53CYP3A4NQO1MAPK1 | |
| SCHEMBL2153438 | 0.73 | TP53 (0.53) | LTA4HTP53CYP3A4NQO1MAPK1 | |
| SCHEMBL21111887 | 0.73 | DRD1 (0.72) | LTA4HTP53CYP3A4NQO1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3466988-B1 | OLIGOMERIZING CATALYST AND METHOD FOR PREPARING ETHYLENE OLIGOMER USING SAME | SK INNOVATION CO LTD (KR) | 2023-11-29 | — | — | EP | disclosed |
| US-11235315-B2 | Oligomerization catalyst and method for preparing ethylene oligomer using same | SK INNOVATION CO., LTD. (KR) | 2022-02-01 | — | — | US | disclosed |
| US-20190308178-A1 | Oligomerization Catalyst and Method for Preparing Ethylene Oligomer Using Same | SK INNOVATION CO, LTD. (KR) | 2019-10-10 | — | — | US | disclosed |
| EP-3466988-A1 | OLIGOMERIZING CATALYST AND METHOD FOR PREPARING ETHYLENE OLIGOMER USING SAME | SK Innovation Co., Ltd. (KR) | 2019-04-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11235315-B2 | Oligomerization catalyst and method for preparing ethylene oligomer using same | AP1M1, NOD2, NOD1 | LTA4H 1421/4885TP53 1915/4885CYP3A4 1114/4885 |
| US-20190308178-A1 | Oligomerization Catalyst and Method for Preparing Ethylene Oligomer Using Same | AP1M1, NOD2, NOD1 | LTA4H 1384/4885TP53 1975/4885CYP3A4 1208/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.